Dr. Aven Lee is a Postdoctoral Research Fellow at the Centre for Clinical Research, The University of Queensland. He obtained his Ph.D. at The University of Queensland. His research is aimed at studying the molecular mechanisms of excitotoxicity which is implicated in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). Dysregulation of the glutamate transport system and loss of glutamate transporters such as EAAT1 and EAAT5 are pathological events that contribute to the death of motor neurons in ALS. Dr Lee has cloned many new (splice-variant) forms of these transporters and created antibodies that can detect where they are localised in the brain and determine their role in normal and pathological states. A second objective of Dr Lee’s research is the study of non-genetic factors in ALS, especially the exposure to gut-derived toxins that are toxic to neurons. These gut microbial metabolites are formed via metabolic breakdown of dietary constituents such as L-carnitine, choline and amino acids. Investigations of gut toxins have been accelerated through the application of targeted mass-spectrometry-based approaches to quantify the concentrations of such in ALS patients and healthy control subjects and the use of bioinformatics to characterise dysregulated pathways/networks. He authored more than 40 publications, including journal articles, conference papers, and book chapters.
Dr. Aven Lee is a Postdoctoral Research Fellow at the Centre for Clinical Research, The University of Queensland. He obtained his Ph.D. at The University of Queensland. His research is aimed at studying the molecular mechanisms of excitotoxicity which is implicated in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). Dysregulation of the glutamate transport system and loss of glutamate transporters such as EAAT1 and EAAT5 are pathological events that contribute to the death of motor neurons in ALS. Dr Lee has cloned many new (splice-variant) forms of these transporters and created antibodies that can detect where they are localised in the brain and determine their role in normal and pathological states. A second objective of Dr Lee’s research is the study of non-genetic factors in ALS, especially the exposure to gut-derived toxins that are toxic to neurons. These gut microbial metabolites are formed via metabolic breakdown of dietary constituents such as L-carnitine, choline and amino acids. Investigations of gut toxins have been accelerated through the application of targeted mass-spectrometry-based approaches to quantify the concentrations of such in ALS patients and healthy control subjects and the use of bioinformatics to characterise dysregulated pathways/networks. He authored more than 40 publications, including journal articles, conference papers, and book chapters.